Kommentar zu: Multiple Nahrungsmittelallergien: Omalizumab erhöht Reaktionsschwellen

• Literatur

• 1 Leung DY, Sampson HA, Yunginger JW. Avon Longitudinal Study of Parents and Children Study Team. et al. Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med 2003; 348: 986-993
• 2 Andorf S, Purington N, Kumar D. et al. A Phase 2 Randomized Controlled Multisite Study Using Omalizumab-facilitated Rapid Desensitization to Test Continued vs Discontinued Dosing in Multifood Allergic Individuals. EClinicalMedicine 2019; 7: 27-38
• 3 Du Toit G, Sayre PH, Roberts G. Immune Tolerance Network LEAP-On Study Team. et al. Effect of Avoidance on Peanut Allergy after Early Peanut Consumption. N Engl J Med 2016; 374: 1435-1443
• 4 Fritscher-Ravens A, Schuppan D, Ellrichmann M. et al. Confocal endomicroscopy shows food-associated changes in the intestinal mucosa of patients with irritable bowel syndrome. Gastroenterology 2014; 147: 1012-1020.e4
• 5 Fritscher-Ravens A, Pflaum T, Mösinger M. et al. Many Patients With Irritable Bowel Syndrome Have Atypical Food Allergies Not Associated With Immunoglobulin E. Gastroenterology 2019; 157: 109-118.e5